These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31467618)

  • 1.
    Wu L; Shang W; Zhao H; Rong G; Zhang Y; Xu T; Zhang J; Huang P; Wang F
    Dis Markers; 2019; 2019():7541857. PubMed ID: 31467618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer.
    Márton É; Lukács J; Penyige A; Janka E; Hegedüs L; Soltész B; Méhes G; Póka R; Nagy B; Szilágyi M
    J Biotechnol; 2019 May; 297():58-65. PubMed ID: 30953675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
    PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
    J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
    Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
    Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
    Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
    Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
    PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
    Chung YW; Bae HS; Song JY; Lee JK; Lee NW; Kim T; Lee KW
    Int J Gynecol Cancer; 2013 May; 23(4):673-9. PubMed ID: 23542579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer.
    Du M; Shi D; Yuan L; Li P; Chu H; Qin C; Yin C; Zhang Z; Wang M
    Sci Rep; 2015 May; 5():10437. PubMed ID: 26014226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum MicroRNA-Based Risk Prediction for Stroke.
    Sonoda T; Matsuzaki J; Yamamoto Y; Sakurai T; Aoki Y; Takizawa S; Niida S; Ochiya T
    Stroke; 2019 Jun; 50(6):1510-1518. PubMed ID: 31136284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Hasanzadeh M; Parizadeh SMR; Hassanian SM; Rezaei-Kalat A; Aghabozorgi AS; Rahimi-Kakhki R; Zargaran B; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(14):1447-1460. PubMed ID: 31284859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
    Yu Z; Qin S; Wang H
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.